Literature DB >> 11316610

Molecular controls of antigen receptor clustering and autoimmunity.

C Krawczyk1, J M Penninger.   

Abstract

Cellular organization of the cytoskeleton, assembly of intracellular signaling complexes and movement of membrane receptors into supramolecular activation complexes (SMACs) are crucial prerequisites for lymphocyte activation and function. Full T-cell activation requires costimulatory signals in addition to antigen-mediated signals. Costimulatory signals facilitate T-cell activation by inducing SMAC formation, resulting in sustained signal transduction, cell-cycle progression and cytokine production. The guanine nucleotide exchange factor Vav1 and the Wiscott-Aldrich syndrome protein (WASP) regulate the actin cytoskeleton in T cells and also regulate SMAC formation. In mice lacking the E3 ubiquitin ligase Cbl-b, the Vav-WASP signaling pathway is active in the absence of costimulation resulting in deregulated cytoskeletal reorganization, enhanced priming and expansion of autoreactive T cells, and the development of autoimmunity. This review discusses the role of Cbl-b, Vav and WASP in the regulation of SMAC formation and the implications for the maintenance of tolerance and the development of autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11316610     DOI: 10.1016/s0962-8924(01)01981-x

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  12 in total

Review 1.  Regulation of hematopoietic cell development and activation by adapter proteins.

Authors:  Gary A Koretzky; Farhad Abtahian; Geo S Derimanov; Sally A Dmowski; Anastasia Guerriero; Martha S Jordan; Jonathan S Maltzman; Benjamin A Olenchock; Andrew L Singer; Jennifer N Wu; Xiao-Ping Zhong
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 2.  Cbl-b in T-cell activation.

Authors:  Magdalena Paolino; Josef M Penninger
Journal:  Semin Immunopathol       Date:  2010-02-21       Impact factor: 9.623

3.  Cbl-b differentially regulates activation-induced apoptosis in T helper 1 and T helper 2 cells.

Authors:  Allison Hanlon; Sihyug Jang; Padmini Salgame
Journal:  Immunology       Date:  2005-12       Impact factor: 7.397

4.  Condensation of the plasma membrane at the site of T lymphocyte activation.

Authors:  Katharina Gaus; Elena Chklovskaia; Barbara Fazekas de St Groth; Wendy Jessup; Thomas Harder
Journal:  J Cell Biol       Date:  2005-10-03       Impact factor: 10.539

5.  Hepatocyte growth factor-induced Ras activation requires ERM proteins linked to both CD44v6 and F-actin.

Authors:  Véronique Orian-Rousseau; Helen Morrison; Alexandra Matzke; Thor Kastilan; Giuseppina Pace; Peter Herrlich; Helmut Ponta
Journal:  Mol Biol Cell       Date:  2006-10-25       Impact factor: 4.138

6.  Sphingolipids are involved in N-methyl-N'-nitro-N-nitrosoguanidine-induced epidermal growth factor receptor clustering.

Authors:  Yun Huang; Jun Yang; Jing Shen; Fanqing F Chen; Yingnian Yu
Journal:  Biochem Biophys Res Commun       Date:  2005-05-06       Impact factor: 3.575

Review 7.  c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses.

Authors:  Christine B F Thien; Wallace Y Langdon
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

8.  Altered lipid raft-associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus.

Authors:  Elizabeth C Jury; Panagiotis S Kabouridis; Fabian Flores-Borja; Rizgar A Mageed; David A Isenberg
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 9.  T-lymphocyte signalling in systemic lupus erythematosus: a lipid raft perspective.

Authors:  E C Jury; P S Kabouridis
Journal:  Lupus       Date:  2004       Impact factor: 2.911

10.  Cbl-b negatively regulates B cell antigen receptor signaling in mature B cells through ubiquitination of the tyrosine kinase Syk.

Authors:  Hae Won Sohn; Hua Gu; Susan K Pierce
Journal:  J Exp Med       Date:  2003-05-27       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.